|
VPS35 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.566200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.033200E-01 |
| Normal-vs-Stage2 |
7.467900E-02 |
| Normal-vs-Stage3 |
2.523900E-02 |
| Normal-vs-Stage4 |
4.934300E-02 |
| Stage1-vs-Stage2 |
5.910600E-01 |
| Stage1-vs-Stage3 |
3.079800E-01 |
| Stage1-vs-Stage4 |
5.235400E-01 |
| Stage2-vs-Stage3 |
8.431800E-01 |
| Stage2-vs-Stage4 |
9.484800E-01 |
| Stage3-vs-Stage4 |
8.938800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.100000E-02 |
| Normal-vs-AfricanAmerican |
5.046000E-01 |
| Normal-vs-Asian |
1.176760E-01 |
| Caucasian-vs-AfricanAmerican |
5.330200E-01 |
| Caucasian-vs-Asian |
9.795000E-01 |
| AfricanAmerican-vs-Asian |
5.657800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.217900E-02 |
| Normal-vs-Female |
7.484400E-02 |
| Male-vs-Female |
3.761600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.763800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.472290E-02 |
| Normal-vs-Age(61-80Yrs) |
1.569600E-02 |
| Normal-vs-Age(81-100Yrs) |
9.522100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.211800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.892100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.394800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.435200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.387400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.934400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.070200E-01 |
| Classical-VS-Follicular |
3.648200E-04 |
| Classical-VS-Other |
3.217800E-01 |
| Classical-VS-Normal |
2.511600E-01 |
| Tall-VS-Follicular |
9.820200E-03 |
| Tall-VS-Other |
2.267400E-01 |
| Tall-VS-Normal |
8.276000E-01 |
| Follicular-VS-Other |
8.421800E-01 |
| Follicular-VS-Normal |
6.562400E-04 |
| Other-VS-Normal |
1.357590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.899100E-03 |
| Normal-vs-N1 |
3.604200E-02 |
| N0-vs-N1 |
9.705600E-01 |
|
|
